ClinicalTrials.gg
Drug

Difamilast clinical trials

Also written OPA-15406.

studies test it
16
open now
2
in phase 3
10
first study started
2012

How each study uses difamilast is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the difamilast studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
12 Feb 2026 · ADQUEY · NDA 219474 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

difamilast
5
1% OPA-15406 Ointment
4
0.3% OPA-15406 Ointment
3
1% OPA-15406
2

Development codes

OPA-15406
8

Studies by the year they started

16 studies that test it; most in 2019 (3)

Studies that test difamilast, by start year
YearStudies
20121
20141
20151
20162
20171
20193
20223
20232
20252

By phase

A phase 1/2 study counts in both.

Phase 1
2
Phase 2
4
Phase 3
10

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 16 · Other 0

Otsuka Pharmaceutical Co., Ltd. (9) · Otsuka Beijing Research Institute (2) · Acrotech Biopharma Inc. (2) · Otsuka Pharmaceutical Development & Commercialization, Inc. (2) · Medimetriks Pharmaceuticals, Inc (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2, 2 in phase 3

Studies that test difamilast, phase 3 first.

Studies

Open first, then newest update. How each study uses difamilast is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 16

Codes

What other systems call difamilast · ClinicalTrials.gg INT001439

  • MeSH (NLM) C000711049difamilastConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) T3U32GLJ0FDIFAMILASTConfirmed FDA, NLM, Wikidata
  • Wikidata Q105335086difamilastConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C169909DifamilastOne source FDA
  • DrugBank DB14987One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.